Global Rosuvastatin Drugs Market Research Report 2022

Rosuvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks.
Due to the COVID-19 pandemic, the global Rosuvastatin Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, the Europe Rosuvastatin Drugs market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Rosuvastatin Drugs landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
5 mg Tablet accounting for % of the Rosuvastatin Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hyperlipidemia And Mixed Dyslipidemia segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Rosuvastatin Drugs include AstraZeneca, Watson, ANGITA and Sun Pharmaceutical Industries, etc. In terms of revenue, the global 3 largest players have a % market share of Rosuvastatin Drugs in 2021.
This report focuses on Rosuvastatin Drugs volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Rosuvastatin Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Rosuvastatin Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
5 mg Tablet
10 mg Tablet
20 mg Tablet
40 mg Tablet
Segment by Application
Hyperlipidemia And Mixed Dyslipidemia
Familial Hypercholesterolemia
Hypertriglyceridemia
Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Atherosclerosis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AstraZeneca
Watson
ANGITA
Sun Pharmaceutical Industries

Frequently Asked Questions